Identifying molecular residual disease (MRD) after treatment of localized lung cancer could
facilitate early intervention and personalization of adjuvant therapies. Here, we apply cancer …

Radiologic screening of high-risk adults reduces lung-cancer-related mortality 1 , 2 ; however,
a small minority of eligible individuals undergo such screening in the United States 3 , 4 . …

Tumor-associated macrophages (TAMs) represent an important cellular subset within the
glioblastoma (WHO grade IV) microenvironment and are a potential therapeutic target. TAMs …

Glioblastoma (GBM) is the most common and highly lethal primary malignant brain tumor in
adults. There is a dire need for easily accessible, noninvasive biomarkers that can delineate …

Objectives: To find and validate generalizable sepsis subtypes using data-driven clustering.
Design: We used advanced informatics techniques to pool data from 14 bacterial sepsis …

Glioblastoma multiforme (GBM) is a highly aggressive malignant brain tumor with fatal
outcome. Tumor-associated macrophages and microglia (TAMs) have been found to be major …

Background & Aims Biomarkers are needed to risk stratify after chemoradiotherapy for
localized esophageal cancer. These could improve identification of patients at risk for cancer …

… Kim LH, Vail D, Azad TD, et al. Expenditures and Health Care Utilization Among Adults With
… Ms Kim and Messrs Vail and Azad contributed equally to this work and share coauthorship. …

Circulating tumor DNA (ctDNA) is a component of cell-free DNA that is shed by malignant
tumors into the bloodstream and other bodily fluids. Levels of ctDNA are typically low, …

… The prospective AOSpine study of CSM reported a perioperative complication rate (within
30 d of surgery) of 15.6% and an overall delayed complication rate (31 d to 2 y following …